In preclinical models, a subcutaneously implanted device was able to continuously monitor vital signs and deliver naloxone automatically and rapidly when it detected opioid overdose.
This article was originally published on this website.
In preclinical models, a subcutaneously implanted device was able to continuously monitor vital signs and deliver naloxone automatically and rapidly when it detected opioid overdose.
This article was originally published on this website.
© 2024 WhizKids.ca